There was an interesting article published this morning in the NY Times regarding osteoporosis drugs and osteonecrosis. According to the article, two groups of people take the osteoporosis drugs which belong to the bisphosphonate family. The first group, those suffering from breast cancer and/or multiple myeloma whose disease has spread to the bone, receive the drug intravenously. The second class of bisphosphonate users are those suffering from osteoporosis. Normally, these folks take a drug like Fosamax orally. If you have questions or concerns about the risk factors associated with Fosamax or other bisphosphonates, consult your physician.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.